The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchChest pain with effort.
How Chelohart works
Chelohart is not a peptide. It is an extract of calf heart muscle, fractionated by size.
What that costs, stated as the missing numbers. Cardiogen is C18H31N7O9, 489.50 Da, isoelectric point 4.18, computed charge about −1.06 at pH 7.4. Chelohart has no formula, no mass, no isoelectric point and no charge, because it is not one substance.
- Oral
On the goal map: Cardiac energetics & heart failure support (Heart, cholesterol & blood pressure)
Research on Chelohart5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
The 'natural' extract counterpart to Cardiogen, sold orally for cardiac support. Practical record is thin and largely indistinguishable from Cardiogen's in what users report.
How the mechanism reads
A heart-tissue peptide complex proposed to support cardiomyocyte function.
MechanisticTwo things at once: the mechanism is a real, testable hypothesis with published cell-level work behind it, and essentially all of that work is one group's, unreplicated at scale.
MechanisticWhere a defined synthetic exists for the same tissue, the extract is the weaker choice on identity grounds alone — Cardiogen's contents are a known sequence, this one's are a process.
Mechanistic
Sources
- Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN. [Polypeptides influence on tissue cell cultures regeneration of various age rats]. Advances in Gerontology 2015;28(1):97-103 [Russian] · PMID 26390619
- Chalisova NI, et al. The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats. Advances in Gerontology 2009 · PMID 20210190
- Khavinson VK. Tissue-specific effects of peptides. Bulletin of Experimental Biology and Medicine 2001;132(2):807-808 · PMID 11713572
- Khavinson VKh, Malinin VV, Chalisova NI, Grigor'ev EI. [Tissue-specific action of peptides in tissue culture of rats of various ages]. Advances in Gerontology 2002;9:95-100 [Russian] · PMID 12096446
- Fedoreyeva LI, et al. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow) 2011;76(11):1210–1219 · PMID 22117547
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters 2003;24(3-4):233–240 · PMID 14523363
- Alsulaimani RA, Quinn TJ (independent — not the Khavinson group). The efficacy and safety of animal-derived nootropics in cognitive disorders: Systematic review and meta-analysis. Cerebral Circulation – Cognition and Behavior 2021;2:100012 · PMID 36324709
Chelohart safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Past or present cancer, because the one published result is p53 down and PCNA up.
- Chest pain, palpitations or breathlessness that has not been investigated.
- Rapid or irregular heartbeat of unknown cause.
- Pregnancy or breastfeeding, as heart-cell proliferation signals matter in fetal development.
What’s expected
- Nothing immediate; the claim is slower normalization of heart-cell protein synthesis.
- Minimal sensation, with occasional mild gut upset.
- Direction of the molecular marker shift is not clearly favorable.
Watch for
- Chest pain with effort.
- Swelling of the lower legs.
- A lump that appears and grows.
Labs that tell you it’s working
- Lipoprotein(a) — Lp(a): an inherited heart risk that no peptide changes, so it keeps you honest.
- Lp-PLA2 Activity: an arterial plaque inflammation marker.
- ADMA & SDMA: endothelial function, if vessel health is the goal.
- hs-CRP: general inflammatory load behind heart disease.
Heart-tissue bioregulator proposed to normalize cardiomyocyte protein synthesis; the lone molecular readout (p53 down, PCNA up) is ambiguous for safety. PMID 20210190 PMID 12096446
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Chelohart FAQ4 common questions
- Is Chelohart approved for human use?
- No. Chelohart is a research compound.
- What is Chelohart researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Lipoprotein(a); Lp-PLA2 Activity; ADMA & SDMA; hs-CRP: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Chelohart: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



